Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (1)
Select solutions
Active Filters (1)
Clear All
13 - 24 of 32 Results
Sort by:
Best Match

Exploring factors impacting and improving cell counting precision
Exploring factors impacting and improving cell counting precision

Establishing a baseline and drug-induced SMN expression profile in SMA disease-relevant human tissues in expedited autopsies
Research in establishing SMN expression level baselines in disease-relevant human tissues across.

Addressing the challenges in modern biotherapeutic development
Explore next-generation approaches to enable the development and characterization of bispecific and multi-specific antibodies

Safety rules with Revvity biotherapeutic workflows
Improve safety and efficacy of your GMP manufacturing workflows with this infographic exploring Revvity instruments, reagents and assays.

Overcoming the technical and economic hurdles of single-cell sequencing
This white paper offers valuable insights from an expert panel discussion on navigating single-cell sequencing challenges to enhance your research outcomes.

Tackling Huntington's disease from all angles
Huntington's Disease research to better characterize early stages of the disease and discover new treatment therapies, while lending support to HD patients and families.

Huntington’s disease: progress and future perspectives
Insight into recent scientific breakthroughs and therapeutic approaches currently being pursued by the HD research community.

Leveraging the microbiome to strengthen immune therapeutic response
Understanding the role bacteria play, whether it be oncogenesis, tumor promotion, or treatment effectiveness, may provide an opportunity for intervention at the microbiome level in favor of cancer regression.

Spotlight research interview: narcolepsy, a neurological autoimmune disorder
Researchers were first to demonstrate direct evidence of autoreactive immune cells in narcolepsy patients, providing evidence of autoimmune basis

Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.

Prolonging ß cell proliferation with a 3D culture system
Disque Platform technology for evaluating drug candidates to treat ß cell loss in patients with diabetes.

An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.